In patients with major depression, abnormalities in baseline cortisol secretion and resistance to negative feedback are well established. However, it is unclear if patients with major depression have alterations in the hypothalamicpituitary-adrenal (HPA) response to stressors. While other challenges to the HPA axis have used endocrine stimuli such as insulin-induced hypoglycemia, we now report of the response to a social stressor in patients withOver the last two decades, an extensive body of work has pointed to a close relationship between stress and major depression. Studies by numerous investigators including Frank et al. (1994) and Brown et al. (1994) have documented the role of stressful life events in the precipitation of depressive episodes. Studies in twins by Kendler et al. (1993) have demonstrated a clear interaction between genetic substrate and a recent stressful life event in the precipitation of a depressive episode. In addition, abnormalities in the hypothalamic-pituitary adrenal (HPA) axis are seen during depression. HPA measures have demonstrated different types of dysregulation at rest or following various endocrine challenges. For example, patients with major depression demonstrate elevated plasma cortisol levels at rest, a finding observed in approximately 50% of depressed patients. This increase in plasma cortisol is particularly evident in the evening, at the nadir of the circadian rhythm (Sachar et al. 1973; Carroll et al. 1976;Rubin et al. 1987;Halbreich et al. 1985;Pfohl et al. 1985). Furthermore, a number of studies have investigated abnormal glucocorticoid feedback, typically using the synthetic steroid dexamethasone but also using the naturally occurring glucocorticoid cortisol (Carroll et al. 1981;Young et al. 1993Young et al. , 1991. These studies generally support the view that there is significant dysregulation of NO . 4 steroid negative feedback mechanisms in major depression. Fewer studies have examined the activational circuits of the LHPA axis in depression, and these studies have been limited to endocrine challenges such as metyrapone, or insulin-induced hypoglycemia (Young et al. 1994;von Bardeleben et al. 1988;Kathol et al. 1992;Lopez et al. 1987). The metyrapone studies suggested increased central drive in the evening (Young et al. 1994), while insulin-induced hypoglycemia revealed elevated basal cortisol and an attenuated ACTH response to the challenge (Kathol et al. 1992;Lopez et al. 1987). Finally, there is evidence that corticotropin-releasinghormone, CRH, which represents the final common path of stress responsiveness in the brain, is elevated in CSF and hypothalamus, and that this elevation may contribute both to the endocrine and psychological profile seen in severe depression (Nemeroff et al. 1984;Roy et al. 1987;Raadsheer et al. 1995Raadsheer et al. , 1994Nemeroff, 1988;Nemeroff et al. 1988).In spite of these findings, it remains difficult to determine what these endocrine changes tell us about the alterations in key neuronal circuits which mediate stress resp...